159 related articles for article (PubMed ID: 26464058)
1. Clinical course and prognostic factors in patients with malignant pheochromocytoma and paraganglioma: A single institution experience.
Choi YM; Sung TY; Kim WG; Lee JJ; Ryu JS; Kim TY; Kim WB; Hong SJ; Song DE; Shong YK
J Surg Oncol; 2015 Dec; 112(8):815-21. PubMed ID: 26464058
[TBL] [Abstract][Full Text] [Related]
2. Paraganglioma: not just an extra-adrenal pheochromocytoma.
Laird AM; Gauger PG; Doherty GM; Miller BS
Langenbecks Arch Surg; 2012 Feb; 397(2):247-53. PubMed ID: 22086065
[TBL] [Abstract][Full Text] [Related]
3. Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years.
Hamidi O; Young WF; Iñiguez-Ariza NM; Kittah NE; Gruber L; Bancos C; Tamhane S; Bancos I
J Clin Endocrinol Metab; 2017 Sep; 102(9):3296-3305. PubMed ID: 28605453
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.
Huang KH; Chung SD; Chen SC; Chueh SC; Pu YS; Lai MK; Lin WC
Int J Urol; 2007 Mar; 14(3):181-5. PubMed ID: 17430251
[TBL] [Abstract][Full Text] [Related]
5. Phaeochromocytomas and paragangliomas: A difference in disease behaviour and clinical outcomes.
Ezzat Abdel-Aziz T; Prete F; Conway G; Gaze M; Bomanji J; Bouloux P; Khoo B; Caplin M; Mushtaq I; Smart J; Kurzawinski TR
J Surg Oncol; 2015 Oct; 112(5):486-91. PubMed ID: 26337393
[TBL] [Abstract][Full Text] [Related]
6. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.
Ayala-Ramirez M; Feng L; Johnson MM; Ejaz S; Habra MA; Rich T; Busaidy N; Cote GJ; Perrier N; Phan A; Patel S; Waguespack S; Jimenez C
J Clin Endocrinol Metab; 2011 Mar; 96(3):717-25. PubMed ID: 21190975
[TBL] [Abstract][Full Text] [Related]
7. One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paraganglioma.
Hescot S; Leboulleux S; Amar L; Vezzosi D; Borget I; Bournaud-Salinas C; de la Fouchardiere C; Libé R; Do Cao C; Niccoli P; Tabarin A; Raingeard I; Chougnet C; Giraud S; Gimenez-Roqueplo AP; Young J; Borson-Chazot F; Bertherat J; Wemeau JL; Bertagna X; Plouin PF; Schlumberger M; Baudin E;
J Clin Endocrinol Metab; 2013 Oct; 98(10):4006-12. PubMed ID: 23884775
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Factors of Malignant Pheochromocytoma and Paraganglioma: A Combined SEER and TCGA Databases Review.
Mei L; Khurana A; Al-Juhaishi T; Faber A; Celi F; Smith S; Boikos S
Horm Metab Res; 2019 Jul; 51(7):451-457. PubMed ID: 30919391
[TBL] [Abstract][Full Text] [Related]
9. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas.
Amar L; Baudin E; Burnichon N; Peyrard S; Silvera S; Bertherat J; Bertagna X; Schlumberger M; Jeunemaitre X; Gimenez-Roqueplo AP; Plouin PF
J Clin Endocrinol Metab; 2007 Oct; 92(10):3822-8. PubMed ID: 17652212
[TBL] [Abstract][Full Text] [Related]
10. Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems.
Wachtel H; Hutchens T; Baraban E; Schwartz LE; Montone K; Baloch Z; LiVolsi V; Krumeich L; Fraker DL; Nathanson KL; Cohen DL; Fishbein L
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4661-70. PubMed ID: 32877928
[TBL] [Abstract][Full Text] [Related]
11. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma.
Kimura N; Takayanagi R; Takizawa N; Itagaki E; Katabami T; Kakoi N; Rakugi H; Ikeda Y; Tanabe A; Nigawara T; Ito S; Kimura I; Naruse M;
Endocr Relat Cancer; 2014 Jun; 21(3):405-14. PubMed ID: 24521857
[TBL] [Abstract][Full Text] [Related]
12. Malignant pheochromocytoma in a population-based study: survival and clinical results.
Wängberg B; Muth A; Khorram-Manesh A; Jansson S; Nilsson O; Forssell-Aronsson E; Tisell L; Ahlman H
Ann N Y Acad Sci; 2006 Aug; 1073():512-6. PubMed ID: 17102119
[TBL] [Abstract][Full Text] [Related]
13. Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades.
Goffredo P; Sosa JA; Roman SA
J Surg Oncol; 2013 May; 107(6):659-64. PubMed ID: 23233320
[TBL] [Abstract][Full Text] [Related]
14. Pheochromocytoma in children.
Ciftci AO; Tanyel FC; Senocak ME; Büyükpamukçu N
J Pediatr Surg; 2001 Mar; 36(3):447-52. PubMed ID: 11226993
[TBL] [Abstract][Full Text] [Related]
15. Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma.
Lee SE; Oh E; Lee B; Kim YJ; Oh DY; Jung K; Choi JS; Kim J; Kim SJ; Yang JW; An J; Oh YL; Choi YL
Oncotarget; 2016 Apr; 7(17):24141-53. PubMed ID: 27007161
[TBL] [Abstract][Full Text] [Related]
16. [Malignant pheochromocytoma: diagnosis and treatment].
Yang D; Li S; Li X; Liu S; Wang H; Han W; Hao J
Zhonghua Wai Ke Za Zhi; 1999 Feb; 37(2):104-5. PubMed ID: 11829794
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of a large series of patients surgically treated for pheochromocytoma.
Khorram-Manesh A; Ahlman H; Nilsson O; Friberg P; Odén A; Stenström G; Hansson G; Stenquist O; Wängberg B; Tisell LE; Jansson S
J Intern Med; 2005 Jul; 258(1):55-66. PubMed ID: 15953133
[TBL] [Abstract][Full Text] [Related]
18. Malignant pheochromocytoma: predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center.
Szalat A; Fraenkel M; Doviner V; Salmon A; Gross DJ
Endocrine; 2011 Apr; 39(2):160-6. PubMed ID: 21069578
[TBL] [Abstract][Full Text] [Related]
19. Metastases but not cardiovascular mortality reduces life expectancy following surgical resection of apparently benign pheochromocytoma.
Timmers HJ; Brouwers FM; Hermus AR; Sweep FC; Verhofstad AA; Verbeek AL; Pacak K; Lenders JW
Endocr Relat Cancer; 2008 Dec; 15(4):1127-33. PubMed ID: 18824558
[TBL] [Abstract][Full Text] [Related]
20. Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy.
Nomura K; Kimura H; Shimizu S; Kodama H; Okamoto T; Obara T; Takano K
J Clin Endocrinol Metab; 2009 Aug; 94(8):2850-6. PubMed ID: 19470630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]